再狭窄に対するシロスタゾール添加による頸動脈ステント留置術

基本情報

NCT ID: NCT01261234
ステータス: 完了
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 707
治験依頼者名: Kobe City General Hospital

概要

CAS-CARE study was conducted to evaluate the inhibitory effect of cilostazol, compared to that of other antiplatelet drugs, on in-stent restenosis following carotid artery stenting (CAS) in patients scheduled to undergo CAS. Study design is Multicenter Prospective Ranodomized Controlled Study, rondomized by cilostazol/non-cilostazol group prior to CAS. 900 patients will be enrolled for 2 years and followed 2 years with in-stent restenosis after CAS, evaluated by carotid ultrasound and angiography.